Medicina, Dermatología y Toxicología
Departamento
![Foto de Medicina, Dermatología y Toxicología](/img/noimage.png)
![Foto de Instituto de Investigación Sanitaria del Hospital Universitario La Paz](/img/noimage_org.png)
Instituto de Investigación Sanitaria del Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria del Hospital Universitario La Paz (28)
2024
-
Bicaval TricValve Implantation in Patients With Severe Symptomatic Tricuspid Regurgitation: 1-Year Follow-Up Outcomes
JACC: Cardiovascular Interventions, Vol. 17, Núm. 1, pp. 60-72
-
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry
Alimentary Pharmacology and Therapeutics
-
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU
Digestive and Liver Disease
-
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
Pharmaceutics, Vol. 16, Núm. 5
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Coronary Obstruction After Transcatheter Aortic Valve Replacement: Insights From the Spanish TAVI Registry
JACC: Cardiovascular Interventions, Vol. 16, Núm. 10, pp. 1208-1217
-
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated with Internal Fistulizing Disease: BIOSCOPE Study from GETECCU
American Journal of Gastroenterology, Vol. 118, Núm. 6, pp. 1036-1046
2022
-
Healthy lifestyle, metabolomics and incident type 2 diabetes in a population-based cohort from Spain
International Journal of Behavioral Nutrition and Physical Activity, Vol. 19, Núm. 1
-
Improving hip fracture care in Spain: evolution of quality indicators in the Spanish National Hip Fracture Registry
Archives of Osteoporosis, Vol. 17, Núm. 1
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Machine-learning-based approach for predicting response to anti-calcitonin gene-related peptide (CGRP) receptor or ligand antibody treatment in patients with migraine: A multicenter Spanish study
European Journal of Neurology, Vol. 29, Núm. 10, pp. 3102-3111
-
Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study
Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients
Cephalalgia, Vol. 42, Núm. 8, pp. 804-809
2021
-
Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)
Critical Care
-
Food-based dietary guidelines around the world: A comparative analysis to update aesan scientific committee dietary recommendations
Nutrients, Vol. 13, Núm. 9
-
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792
-
Persistent headache after COVID-19: Pathophysioloy, clinic and treatment
Neurology Perspectives, Vol. 1, pp. S31-S36
2020
-
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients with Inflammatory Bowel Disease: Results from the Eneida Registry
Inflammatory Bowel Diseases, Vol. 26, Núm. 4, pp. 606-616
-
Glycemic variability: prognostic impact on acute ischemic stroke and the impact of corrective treatment for hyperglycemia. The GLIAS-III translational study
Journal of Translational Medicine, Vol. 18, Núm. 1